The new rules address the coordination of FAMLI with other benefits and establish penalties for violations.
The Colorado Department of Labor and Employment recently issued rules addressing the coordination of benefits and reimbursement of advance payments under the state family and medical leave insurance program, “FAMLI.” The rules address the interplay between FAMLI benefits and other leave benefits, such as workers’ compensation, unemployment and employer-provided paid leave. Importantly, the rules establish a penalty structure for employer violations. The rules take effect Jan. 1, 2025.
FAMLI
FAMLI was passed in 2020 as a ballot measure. On Jan. 1, 2024, the program, funded by employer and employee contributions, began providing 12 weeks of paid leave per year for employees to:
- Bond with a new child;
- Care for their own serious health condition;
- Care for a family member with a serious health condition;
- Make arrangements for a family member’s military deployment; and
- Address the immediate safety needs and impact of domestic violence and sexual assault
Coordination of Benefits Rules
During the course of the FAMLI rollout, the department has issued sets of regulations addressing different aspects of the program. The new rules for the coordination of benefits set forth the following penalties for specific employer violations:
- $50 per employee per day for violating provisions concerning receipt of FAMLI benefits and employer-provided paid leave;
- $500 per employee per day for failing to maintain health care benefits during FAMLI leave; and
- $500 per violation of provisions about FAMLI benefits, short-term disability benefits, long-term disability benefits, and benefits from a separate bank of time off solely for the purpose of paid family and medical leave.
Related Blogs
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
The Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
Employer Response to Pharma Shifts
Volatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More
White House Launches TrumpRx, Unveils Drug Prices
On Feb. 5, President Donald Trump announced the launch of TrumpRx.gov, a federally operated website to help individuals buy prescription medications at discounted cash ...
Read More
DOL Issues Updated Model Employer CHIP Notice
The U.S. Department of Labor (DOL), through its Employee Benefits Security Administration (EBSA), has released a new model Employer CHIP Notice with information current ...
Read More
Prescription Drug Reporting (RxDC Report)
The No Surprises Act (NSA), enacted as part of the Consolidated Appropriations Act, 2021 (CAA), includes transparency provisions requiring group health plans to report ...
Read More
Major Federal PBM Reforms Enacted as DOL Proposes New PBM Fee-Disclosure Rule
Federal oversight efforts directed at the pharmaceutical benefit manager (PBM) industry have expanded in recent years, culminating in several significant actions. On Feb. 3, ...
Read More